Results 161 to 170 of about 270,524 (304)

Schema Therapy for Individuals With Subthreshold Autistic Traits and Recurrent Depressive Disorder: A Case Study. [PDF]

Cureus
Murakami T, Oshima F, Morimoto T, Annaka H.   +3 more
europepmc   +1 more source

Evaluating the role of maladaptive personality traits in schema therapy and cognitive behavioural therapy for depression. [PDF]

Psychol Med, 2023
Rek K, Kappelmann N, Zimmermann J, Rein M, Egli S, Kopf-Beck J.   +5 more
europepmc   +1 more source

Self‐Immolative Activatable Nanoassembly toward Immuno‐Photodynamic Therapy in TME

Advanced Functional Materials, EarlyView.
A quinone methide‐gated, self‐immolative, H2O2‐responsive nano‐photosensitizer (Pyz/PS) is developed for targeted immuno‐photodynamic therapy. Pyz/PS selectively activates within tumor microenvironments, restores photosensitizer activity, generates ROS, and depletes intracellular GSH, enhancing oxidative stress.
Jing Li, E Pang, Snehasish Debnath, Jia Hong, Aojun Qiu, Dongeun Kim, Goeun Kim, Minhuan Lan, Min‐Goo Lee, Qian‐Yong Cao, Jong Seung Kim   +10 more
wiley   +1 more source

Emotion-focused vs. cognitive interventions of schema therapy for borderline personality disorder: effects on neural emotion regulation networks - study protocol. [PDF]

Borderline Personal Disord Emot Dysregul
Smesny S, Langbein K, Krylova M, Li M, Izyurov I, Gussew A, Güllmar D, Walter M, Wagner G, Reichenbach JR.   +9 more
europepmc   +1 more source

Implementation of Drug‐Induced Rhabdomyolysis and Acute Kidney Injury in Microphysiological System

Advanced Functional Materials, EarlyView.
A modular Muscle–Kidney proximal tubule‐on‐a‐chip integrates 3D skeletal muscle and renal proximal tubule tissues to model drug‐induced rhabdomyolysis and acute kidney injury. The coculture system enables dynamic tissue interaction, functional contraction monitoring, and quantification of nephrotoxicity, revealing drug side effect‐induced metabolic ...
Jaesang Kim, Zhuo Feng Lee, Gi‐Dong Sim, Sejoong Kim, Jessie S. Jeon   +4 more
wiley   +1 more source

Treating complex PTSD with Schema Therapy, ImRs and EMDR: a review and case study. [PDF]

Eur J Psychotraumatol
van Hemert MTC, de Jong PM, Brouwer TR, Zoon L, Gunst E, Claes L, Morrens M.   +6 more
europepmc   +1 more source

Correction to: Design of an international multicentre RCT on group schema therapy for borderline personality disorder. [PDF]

BMC Psychiatry, 2022
Wetzelaer P, Farrell J, Evers SMAA, Jacob GA, Lee CW, Brand O, van Breukelen G, Fassbinder E, Fretwell H, Harper RP, Lavender A, Lockwood G, Malogiannis IA, Schweiger U, Startup H, Stevenson T, Zarbock G, Arntz A.   +17 more
europepmc   +1 more source

Smart, Bio‐Inspired Polymers and Bio‐Based Molecules Modified by Zwitterionic Motifs to Design Next‐Generation Materials for Medical Applications

Advanced Functional Materials, EarlyView.
Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz, Jonas De Breuck, Sahar Salehi, Meike N. Leiske   +3 more
wiley   +1 more source

Integrating Positive Schemas in Schema Therapy for Cluster C Personality Disorders in Older Adults: A Multiple Baseline Study. [PDF]

Clin Psychol Psychother
van Donzel L, Ouwens MA, van Alphen SPJ, Bouwmeester S, Bachrach N, Videler AC.   +5 more
europepmc   +1 more source

Correction: Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy. [PDF]

BMC Psychiatry, 2023
Kool M, Van HL, Bartak A, de Maat SCM, Arntz A, van den Eshof JW, Peen J, Blankers M, Bosmans JE, Dekker JJM.   +9 more
europepmc   +1 more source